OtherArticle
DEMONSTRATION OF DOCOSAHEXAENOIC ACID (DHA) AS A BIOAVAILABILITY ENHANCER FOR CYP3A SUBSTRATES: IN VITRO AND IN VIVO EVIDENCE USING CYCLOPORIN IN RATS
Vilasinee Hirunpanich, Jun Katagi, Benjabhorn Sethabouppha and Hitoshi Sato
Drug Metabolism and Disposition November 18, 2005, DOI: https://doi.org/10.1124/dmd.105.007088
Vilasinee Hirunpanich
Jun Katagi
Benjabhorn Sethabouppha
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
DEMONSTRATION OF DOCOSAHEXAENOIC ACID (DHA) AS A BIOAVAILABILITY ENHANCER FOR CYP3A SUBSTRATES: IN VITRO AND IN VIVO EVIDENCE USING CYCLOPORIN IN RATS
Vilasinee Hirunpanich, Jun Katagi, Benjabhorn Sethabouppha and Hitoshi Sato
Drug Metabolism and Disposition November 18, 2005, DOI: https://doi.org/10.1124/dmd.105.007088
OtherArticle
DEMONSTRATION OF DOCOSAHEXAENOIC ACID (DHA) AS A BIOAVAILABILITY ENHANCER FOR CYP3A SUBSTRATES: IN VITRO AND IN VIVO EVIDENCE USING CYCLOPORIN IN RATS
Vilasinee Hirunpanich, Jun Katagi, Benjabhorn Sethabouppha and Hitoshi Sato
Drug Metabolism and Disposition November 18, 2005, DOI: https://doi.org/10.1124/dmd.105.007088
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement